Perspective · 25 Feb 2025
EditorialPublished 10 Jan 2018
Current Status of Gadolinium Retention in the Brain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gadolinium (Gd3+) based contrast agents previously demonstrated safe administration and were associated with minimal events of adverse reactions until NSF and gadolinium deposits were found in the brain. Gadolinium is a paramagnetic earth lanthanoid element with a ferromagnetic property that is suitable for intravenous administration. Recently, a series of studies raised their concern over the higher risk of developing NSF when administering nonionic linear agents such as gadodiamide and gadoversetamide
Subjects
Radiology & ImagingAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Radiology.
Research article · 24 May 2024
Histological Quantification of Defined Thrombi with Spectral CT Analysis: An in vitro-Study using Ovine Blood-Samples
Opinion · 28 Dec 2023
Radiation Chemistry: Resolving Molecular Transformations through Ionizing Radiation
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Radiology
- SubjectRadiology & Imaging
- BylineArticles whose byline prints “Bakhour D”
- BylineArticles whose byline prints “Saade C”
